ORAMED PHARMACEUTICALS INC.·4

Nov 8, 4:30 PM ET

Kidron Miriam 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Nov 8, 2024

Insider Transaction Report

Form 4
Period: 2024-11-07
Kidron Miriam
DirectorChief Scientific Officer
Transactions
  • Award

    Common Stock

    2024-11-07+30,000793,666 total
Footnotes (1)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file
  • 4
    ownership.xmlPrimary